Curaleaf International and Jupiter Research Partnership Obtain EU Medical Device Certification for First Liquid Inhalation Device
Curaleaf International and Jupiter Research LLC, announce the first liquid inhalation device has received an EU medical device certification.
Image | adobe.stock/johnalexandr
In a recent press release, Curaleaf International announced that through working together with Jupiter Research LLC, the companies were able to obtain an EU medical device certification (Regulation (EU) 2017/745) for the first handheld liquid inhalation device created for “precise medical cannabis administration,” (1,2).
The device will be labeled as a certifiedClass IIa medical device and meets the regulatory standards in Europe (1,2). The press release (1,2) mentioned that “A comprehensive technical file and full EU Declaration of Conformity were assessed and approved by a recognized EU Notified Body, validating the device's quality, safety, and clinical robustness.” It also detailed that the device contains a magnetic snap-in cartridge, as well as a power supply that is rechargeable.
With the certification from the EU, healthcare professionals will be able to recommend the device in European countries, Canada, regions throughout Australasia, and the UK (1,2). Additionally, the device will be able to be offered in various global markets once it has been commercialized.
Boris Jordan, Chairman and CEO of Curaleaf, said (1,2), “Achieving EU medical certification is more than a regulatory milestone—it's a signal that medical cannabis innovation is moving into the mainstream of global healthcare. We're proud to offer a device that meets the highest standards of safety and quality, and we look forward to supporting patients and healthcare providers across Europe and beyond with a new, accurate and discrete option for treatment.”
TILT's Chief Executive Officer Tim Conder, commented (1,2), “Partnering with Curaleaf International on this project has been a natural extension of our long-standing partnership in the US. By delivering industry-leading, user-friendly solutions, our collaboration exemplifies how technology can revolutionise healthcare. Achieving EU medical certification on IP developed by our subsidiary Jupiter Research, validates the robustness of our engineering and R&D functions and sets a new benchmark for the industry.”
References
- Curaleaf International, in partnership with Jupiter Research, secures EU Medical Device Certification for Europe’s first handheld liquid inhalation device https://curaleafinternational.com/curaleaf-international-achieve-eu-certification-for-the-first-handheld-liquid-inhalation-device-for-medical-cannabis/ (accessed May 16, 2025).
- Curaleaf International. Curaleaf International, in partnership with Jupiter Research, secures EU Medical Device Certification for Europe’s first handheld liquid inhalation device https://www.prnewswire.com/news-releases/curaleaf-international-in-partnership-with-jupiter-research-secures-eu-medical-device-certification-for-europes-first-handheld-liquid-inhalation-device-302451697.html (accessed May 16, 2025).
